论文部分内容阅读
二脱氧肌苷（didanosine）和二脱氧胞苷（zalcitabine）通常用于不能耐受齐多夫定或用药无效的人免疫缺陷病毒（HIV）感染的患者，但其作为二线治疗的相对有效性和安全性尚无定论。本文对比研究了艾滋病患者应用这两种药物的疗效、存活率、CD4淋巴细胞计数变化和副作用。方法在
Didanosine and Zalcitabine are commonly used in patients who can not tolerate zidovudine or who are ineffective with human immunodeficiency virus (HIV) infection but whose relative effectiveness as second-line treatment and Security is inconclusive. This article compared the efficacy of these two drugs in patients with AIDS, survival, CD4 lymphocyte count changes and side effects. Method at